Logo of Phnom Penh Post newspaper Phnom Penh Post - Philippines’ $21M remdesivir buy a ‘waste of money’



Philippines’ $21M remdesivir buy a ‘waste of money’

Content image - Phnom Penh Post
The Philippines’ Department of Health purchased one billion pesos ($21 million) worth of remdesivir to treat Covid-19 patients. GILEAD SCIENCES INC

Philippines’ $21M remdesivir buy a ‘waste of money’

Two Philippine House lawmakers on May 9 criticised the Department of Health (DoH) for buying one billion pesos ($21 million) worth of remdesivir even after the World Health Organisation (WHO) had rejected the use of the drug in Covid-19 treatment.

Anakalusugan Representative Michael Defensor and House Deputy Speaker Lito Atienza also questioned the DoH’s decision to push through with the transaction, which they described as a waste of money.

“We consider all new purchases of remdesivir as reckless and foolish spending in light of the WHO recommendation, and considering that [the] government is scrounging for money to buy more Covid-19 vaccines and pay for the 2,000-peso cash aid for every Filipino contemplated under the Bayanihan 3 bill,” Defensor said in a statement.

He warned that further purchases of remdesivir might be deemed as transactions highly detrimental to the government under the Anti-Graft and Corrupt Practices Act.

In a separate statement, Atienza questioned the DoH’s “wasteful double standard” of promoting a very expensive drug such as remdesivir while ignoring other potential low-priced treatments like human-grade ivermectin that he said costs only 35-40 pesos per capsule.

The DoH did not respond to requests for comment.

“The DoH should stop importing and using remdesivir. Otherwise, the public will start suspecting that some [DoH] officials are making money on the purchases,” Atienza said.

“Other wealthy nations can throw their money away on remdesivir if they want to, but in our case, we simply can’t afford to,” he added.

Both Atienza and Defensor have been pushing for the use of ivermectin to treat and prevent Covid-19 despite the WHO’s warning that there was not enough evidence to show the anti-parasitic drug could be used effectively against the coronavirus.

The issue has also divided the medical community, pitting doctors against each other. In particular, a doctor and Inquirer columnist advocating the usage of ivermectin wrote the Healthcare Professionals Alliance Against Covid-19 (HPAAC) last week to demand that the group “correct … the disinformation you had caused and apologise”.

“If you fail to correct the injustice you had caused the medical volunteers and other ivermectin advocates within 72 hours, then we shall be compelled to exhaust all possible legal remedies to seek redress for this grave injustice,” Dr Rafael Castillo said in his letter that he also sent to the DoH, Professional Regulation Commission and Food and Drug Administration (FDA).

Castillo, who took part in the April 29 mass distribution of ivermectin led by Defensor in Quezon City, said that he wrote the letter because he wanted to stand up for the other doctors and medical volunteers who favour the use of the drug “but [were] subjected to [this kind of] humiliation and rebuke”.

“We’re not saying that ivermectin is a miracle drug. It’s not. But it’s safe and it may treat Covid,” Castillo stressed, adding that he was only being “pragmatic” given the scarcity of Covid treatments and vaccines.

Around 200 people each got 10 ivermectin capsules from Defensor and Sagip Representative Rodante Marcoleta during the mass distribution.

Days after, at least 41 medical groups and societies under the HPAAC urged the public not to use the drug and said its distribution was in direct violation of the FDA’s regulatory practices.

It backed the stand of the Philippine College of Physicians (PCP) and Philippine Medical Association, which had warned against the use of the drug. It also expressed support for the position of the Philippine Pharmacists Association, which had said the widespread distribution of ivermectin could be in violation of the Philippine Pharmacy Act and should therefore be investigated by the DoH and FDA.

“If they are found at fault, we also call on the Professional Regulation Commission to investigate and hold them liable for breaking the law,” the HPAAC said.

But in a phone interview on May 9, Castillo said the groups had already reached out to him “to resolve the matter among ourselves, a collegial body”.

Dr Tony Leachon, a former PCP president, said he supported the stand of the medical groups. According to him, he and Castillo have both agreed to disagree.

“Respect is key. Respect [for] oneself. Respect [for] others’ opinions [and] responsibility for your actions,” Leachon said.

PHILIPPINE DAILY INQUIRER/ASIA NEWS NETWORK

MOST VIEWED

  • Restrictions re-imposed in capital as Covid cases surge

    Amid the ongoing community outbreak of Covid-19, which has shown no sign of subsiding with 750 infections and 10 deaths reported on June 2 alone, the Phnom Penh Municipal Administration has decided to re-impose the suspension of all occupations and business activities deemed as posing high risk of

  • Phnom Penh-Sihanoukville expressway 51% complete

    The construction of the nearly $2 billion Phnom Penh-Sihanoukville Expressway is 51.35 per cent complete and is expected to be finished in 2023, according to Ministry of Public Works and Transport secretary of state Vasim Sorya. Invested in by Cambodian PPSHV Expressway Co Ltd, the first expressway in

  • First 7-Eleven store to open mid-June, ambassador says

    Thai retail conglomerate CP All Pcl will open Cambodia’s first 7-Eleven convenience store in mid-June, Cambodian ambassador to Thailand Ouk Sorphorn told The Post on June 1. The Bangkok-listed 7-Eleven franchise operator, the retail arm of Charoen Pokphand Group Co Ltd, granted CP All (Cambodia)

  • With herd immunity likely in 2022, is Cambodia ready to reopen for tourism?

    The government aims to inoculate 80 per cent of the target population by June next year, giving it a head start among regional peers to reboot the sector but first, it has to do a few things to up its game A sign on a glass

  • US embassy guard gets Covid despite two doses of Pfizer jab

    The Covid-19 tracking commission on June 4 said a security guard at the US embassy in Phnom Penh had contracted the novel coronavirus, despite having received a second dose of the Pfizer-BioNTech shot two weeks ago. Embassy spokesperson Chad Roedemeier confirmed the SARS-CoV-2 infection to The

  • US wants 'full access' to Ream Naval Base

    On June 11, the US embassy's Defense Attaché Colonel Marcus M Ferrara visited Ream Nava Base in coordination with Cambodian officials following the recent approval of Prime minister Hun Sen to allay the concerns on Chinese military presence at the base as raised by US Deputy